Skip to content

Fresenius Medical Care Responds to Chilean Earthquake Emergency

| Press release

Fresenius Medical Care Chile is working to maintain operation of its clinic network and continue ensuring lifesaving dialysis treatment for patients in the country’s recently affected earthquake region. Of the company’s 28 dialysis clinics in the country, all but the operations in the Huechuraba area north of the nation’s capital were functioning again within 48 hours of the initial tremor. Patients from Huechuraba received treatment at other clinics within the company’s network. The Feb. 27 early morning offshore tremor registered 8.8 in magnitude and ravaged various portions of the country.

Contributing to further recovery efforts in the affected region, Fresenius Medical Care Chile donated two water treatment units suited for dialysis applications. The company augmented this initiative with technical assistance furnished by a team of water treatment unit specialists from Fresenius Medical Care Chile as well as Fresenius Medical Care Argentina. Working in the epicenter region, this crew has provided support for private clinics and public health care facilities which are not part of the Fresenius Medical Care network but also were impacted by the quake.Working closely with the Chilean Ministry of Health’s dialysis division coordinator, the Fresenius Medical Care team arranged contingent back-up capacities at its clinics for the treatment of 400 patients from affected areas, if necessary. Furthermore, Fresenius Medical Care Chile’s peritoneal dialysis equipment also stood ready to provide continuous ambulatory peritoneal dialysis for the urgent treatment of 50 patients if requested by authorities. In addition to joint efforts with various other organizations, the company activated online Internet communications to update patients, clients and staff via its web site, providing information about patient care, staff availability and the operational status of its clinics.

Coordinating activities to ensure the treatment of individuals with chronic kidney disease, the company also teamed efforts to provide services for patients from other providers and regions seriously impacted by the tremor. Approximately 2,400 patients usually receive treatment in clinics located in the area affected by the quake. With service disruptions affecting roughly half of these persons, health authorities have been coordinating transfers of patients to other locations for treatment.

Fresenius Medical Care Chile provides roughly 360,000 dialysis treatments annually. The company is maintaining its monitoring of the contingency situation and is continuing to provide assistance and implement all necessary relief measures within its capacity.


Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,890,000 individuals worldwide. Through its network of 2,553 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 195,651 patients around the globe. Fresenius Medical Care also is the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P).

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.